Head Office
Novartis International AG
CH-4002 Basel
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 - 17:00, GMT+1
(Central European Time)

Novartis International AG
Investor Relations
P.O. Box
CH-4002 Basel
Switzerland

Global Media Relations
Eric Althoff
Basel, Switzerland

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

pane 4 content

Corporate publications

Download or order key corporate publications using the tabs below. The Annual Report and 20-F contain our complete audited financial statements.

Annual Report 2012

Visit the annual report 2012 page
Form 20-F 2012

Documents Novartis strategy in line with requirements of the US Securities and Exchange Commission (SEC)
- English (PDF, 2 MB)
Connecting with patients

Describes our access-to-medicine programs and pro bono research
- English (PDF, 512 KB)
Novartis Venture Fund Activity Report

Reviews annual achievements of the Novartis Venture Fund
- English (2 MB)
- View previous issues of the Venture Fund Activity Report
Novartis Swiss Passport

Novartis Switzerland at a glance
- English (1.3 MB)
- German (1.3 MB)
- French (1.3 MB)